Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: Role of inflammatory burden and treatment on joint space width in psoriatic arthritis—a high-resolution peripheral quantitative computed tomography study

Fig. 4

Differences in minimum JSW according to treatment. *p < 0.05. A csDMARDs; B bDMARDs. Patients receiving csDMARDs (MCPJ 3) and bDMARDs (MCPJ 2–3) had significantly lower and higher Min JSW respectively, compared to non-users. JSW, joint space width; MCPJ, metacarpophalangeal; csDMARDs, conventional synthetic disease-modifying anti-rheumatic drugs; bDMARDs, biologic disease-modifying anti-rheumatic drugs

Back to article page